ArticleOncotarget2018

Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer.

Yun Gyoung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.